Bone growth in thalassaemic children

Area of Science:

• Pediatric Endocrinology
• Orthopedics
• Hematology

Background:

• Thalassemia is a genetic blood disorder affecting hemoglobin production.
• Bone abnormalities are a known complication in children with thalassemia.
• Understanding skeletal growth patterns is crucial for managing thalassemia complications.

Purpose of the Study:

• To investigate the impact of thalassemia on metacarpal bone growth in children.
• To compare bone length and width dimensions between thalassemic and control groups.
• To assess the correlation between thalassemia and bone age retardation.

Main Methods:

• X-ray measurements of the 3 middle metacarpal bones (length and width) were performed.
• A cohort of 61 children with thalassemia and 35 healthy controls (aged 5-13 years) was studied.
• Bone age was assessed in both groups.

Main Results:

• Thalassemic children exhibited normal bone length growth until age 11, followed by reduced growth.
• Bone width growth in thalassemic children exceeded controls until age 11, then became comparable.
• A higher proportion of thalassemic children showed bone age retardation after 7 years of age.

Conclusions:

• Thalassemia significantly affects metacarpal bone growth, particularly after age 11.
• Altered bone width and length patterns are observed in children with thalassemia.
• Bone age retardation is a more frequent finding in thalassemic children over 7 years old.